Location · Bethesda, MD
Clinical trials in Bethesda, MD
293 recruiting studies have a site in Bethesda, and 270 of them accept healthy volunteers.
293 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
Ono Pharmaceutical Co., Ltd.
- Location
- Bethesda, MD + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Rapport Therapeutics Inc.
- Location
- Bethesda, MD + 13 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2/Phase 3
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Cabaletta Bio
- Location
- Bethesda, MD + 29 other US sites
- Eligibility basics
- Ages 6–75
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Akero Therapeutics, Inc
- Location
- Bethesda, MD + 130 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Novartis Pharmaceuticals
- Location
- Bethesda, MD + 42 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Xenon Pharmaceuticals Inc.
- Location
- Bethesda, MD + 44 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Xenon Pharmaceuticals Inc.
- Location
- Bethesda, MD + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Gilead Sciences
- Location
- Bethesda, MD + 53 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
Jazz Pharmaceuticals
- Location
- Bethesda, MD + 20 other US sites
- Eligibility basics
- Ages 12–75
- RecruitingPhase 2
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Supernus Pharmaceuticals, Inc.
- Location
- Bethesda, MD + 36 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
AstraZeneca
- Location
- Bethesda, MD + 104 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Takeda
- Location
- Bethesda, MD + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss
Skylark Bio Inc.
- Location
- Bethesda, MD + 3 other US sites
- Eligibility basics
- Ages 10 mo–7
- RecruitingPhase 2
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
CSL Behring
- Location
- Bethesda, MD + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- Bethesda, MD + 112 other US sites
- Eligibility basics
- Ages 45+
- Recruiting
Transdermal Compress IDE Study
Balmoral Medical company
- Location
- Bethesda, MD + 8 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingPhase 3
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Italfarmaco
- Location
- Bethesda, MD + 12 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
Zopa Retreatment and Vector Shedding in Adults With RRP
Precigen, Inc
- Location
- Bethesda, MD + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Kartos Therapeutics, Inc.
- Location
- Bethesda, MD + 57 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
SK Life Science, Inc.
- Location
- Bethesda, MD + 6 other US sites
- Eligibility basics
- Ages 4–55
- RecruitingPhase 2
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Praxis Precision Medicines
- Location
- Bethesda, MD + 7 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteers
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
National Cancer Institute (NCI)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 2+
- RecruitingHealthy volunteers
Natural History and Development of Spondyloarthritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 2–99
- RecruitingHealthy volunteers
Brain Stimulation and Vision Testing
National Institute of Mental Health (NIMH)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 18–50